MedTrace Logo

Physical Capacity and Activity in Children With Congenital Heart Disease

NCT03275844 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2017-09-08

No results posted yet for this study

Summary

Congenital malformations correspond to defects in organ morphogenesis identifiable at birth or intrauterine life, affecting 2-3% of births. Inside of these malformations, Congenital Heart Disease corresponds, in particular, to structural defects of the heart or major blood vessels thereof may or may not be associated with other types of syndromes.The resolution is usually surgical.

Also, these patients present a decrease in physical fitness, psychological imbalance, lower quality of life and risk significant morbidity and mortality from respiratory infections among other problems.

This can have severe consequences for health in the medium and long term. The habits acquired during childhood and adolescence are determinant for the adult life, being relevant levels of activity and physical condition, especially in children with pathologies.

In this way, it is vital to know from childhood parameters that indicate the baseline state of these patients according to the levels of physical activity, exercise capacity, nutritional status and quality of life. These will be key indicators to take into account in the future, to adapt rehabilitation plans that will reduce the effects of their condition.

The objective of this protocol is To characterize the levels of Activity, and Physical Capacity of children with congenital heart disease regularly treated at the Cardiovascular Center of Dr. Luis Hospital Calvo Mackenna, compared to healthy children matched by age and sex.

Conditions

  • Heart Defects, Congenital
  • Tetralogy of Fallot

Interventions

PROCEDURE

Physical activity assessment

Assessment of Moderate-to-vigorous physical activity

Sponsors & Collaborators

  • Rodrigo Torres

    lead OTHER

Principal Investigators

  • Homero Puppo, MSc · Univeridad de Chile

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-03-01
Completion
2018-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03275844 on ClinicalTrials.gov